Search - tctmd.com

Displaying 881 - 900 of 3211

Sort: Relevancy | Date

Presentation TCT 2023

TCT 772: Transcatheter Electrosurgical Leaflet Splitting to Prevent TAVR-induced Coronary Obstruction in Stented vs. Stentless Bioprosthetic Aortic Valves: Results From the Multicenter EURO-BASILICA Registry

Presenter: Ines Richter

October 24, 2023

Presentation TCT 2023

TCT 420: Clinical Outcomes of TAVR in Patients with Degenerative Aortic Root Bioprosthesis

Presenter: Nikolaos Diakos

October 24, 2023

Presentation TCT 2023

Trans-Esophageal Imaging to Direct and Document Leaflet Splitting Procedures During Valve-in-Valve TAVR

Presenter: Philippe Pibarot

October 24, 2023

Presentation TCT 2023

TCT 231: Clinical Outcomes in Valve in Valve Transcatheter Aortic Valve Implantation are Comparable to Native Valve Transcatheter Aortic Valve Implantation

Presenter: Kimberley Hemelrijk

October 24, 2023

Presentation TCT 2023

A Novel Transfemoral Aortic Valve Replacement System (Hanchor Valve) for Pure Native Aortic Regurgitation (PNAR)

Presenter: Wenzhi Pan

October 24, 2023

Presentation TCT 2023

TCT 217: Two-year Outcomes of Valve-in-Valve Using New Generation Transcatheter Devices Compared with Redo-SAVR

Presenter: Takashi Nagasaka

October 24, 2023

Presentation TCT 2023

TCT 236: Surgical Bailout in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation

Presenter: Hugo Aarts

October 24, 2023

Presentation TCT 2023

DurAVR Transcatheter Heart Valve: Early Feasibility Study

Presenter: Azeem Latib

October 24, 2023

Presentation TCT 2023

TCT 89: Comparison of In-hospital Outcomes and Long-Term Survival for Valve-in-Valve Transcatheter Aortic Valve Replacement versus The Benchmark Native Valve Transcatheter Aortic Valve Replacement Procedure

Presenter: Anthony Matta

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

Robotically Developed Polymeric-Based Leaflet Technology (Foldax): Technology and Clinical Program Update

Presenter: Isaac George

October 24, 2023

Presentation TCT 2023

TCT 769: Impact of Commissural Alignment on Coronary Access After Redo-TAVR With BASILICA or Chimney Stenting in Degenerated Supra-Annular Self-Expanding Platforms.

Presenter: Alessandro Beneduce

October 24, 2023

Presentation TCT 2023

TCT 745: Indications and 3-Year Outcomes of Redo-TAVR for Degenerated Transcatheter Aortic Valves: Experience from a Single High-Volume Center in Germany

Presenter: Ines Richter

October 24, 2023

Presentation TCT 2023

TCT 676: Safety and Early Outcomes of the Navitor Transcatheter Heart Valve: A Multicenter 'Real World' Study in the United Kingdom

Presenter: APURVA BHARUCHA

October 24, 2023

Presentation TCT 2023

Comparison of Two Self-Expanding Transcatheter Heart Valves for Degenerated Surgical Bioprostheses: The AVENGER Multi-Center Registry

Presenter: Won-Keun Kim

October 24, 2023

Presentation TCT 2023

TCT 716: Impact of Different Lifetime Management Strategies on Coronary Access: Valve-in-Valve versus TAVR-in-TAVR

Presenter: Francesco Giannini

October 24, 2023

Presentation TCT 2023

Pharmacotherapy to Slow AS Progression and Protect the Heart

Presenter: Brian Lindman

October 24, 2023

Presentation TCT 2023

TCT 574: Estimating risks to coronary obstruction and prosthesis-patients mismatch after redo-transcatheter aortic valve replacement using computed tomography-derived 2nd transcatheter aortic valve sizing

Presenter: Miho Fukui

October 24, 2023

Presentation TCT 2023

TCT 610: Predictors of Readmission and Resource Utilization in Transcatheter Aortic Valve Implantation with and without Mitral Stenosis - A National Readmission Database Study

Presenter: Shafaqat Ali

October 24, 2023

Presentation TCT 2023

Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial

Presenter: Josep Rodés-Cabau

October 24, 2023

Advertisement

TCT 772: Transcatheter Electrosurgical Leaflet Splitting to Prevent TAVR-induced Coronary Obstruction in Stented vs. Stentless Bioprosthetic Aortic Valves: Results From the Multicenter EURO-BASILICA Registry

TCT 420: Clinical Outcomes of TAVR in Patients with Degenerative Aortic Root Bioprosthesis

Trans-Esophageal Imaging to Direct and Document Leaflet Splitting Procedures During Valve-in-Valve TAVR

TCT 231: Clinical Outcomes in Valve in Valve Transcatheter Aortic Valve Implantation are Comparable to Native Valve Transcatheter Aortic Valve Implantation

A Novel Transfemoral Aortic Valve Replacement System (Hanchor Valve) for Pure Native Aortic Regurgitation (PNAR)

TCT 217: Two-year Outcomes of Valve-in-Valve Using New Generation Transcatheter Devices Compared with Redo-SAVR

TCT 236: Surgical Bailout in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation

DurAVR Transcatheter Heart Valve: Early Feasibility Study

TCT 89: Comparison of In-hospital Outcomes and Long-Term Survival for Valve-in-Valve Transcatheter Aortic Valve Replacement versus The Benchmark Native Valve Transcatheter Aortic Valve Replacement Procedure

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Robotically Developed Polymeric-Based Leaflet Technology (Foldax): Technology and Clinical Program Update

TCT 769: Impact of Commissural Alignment on Coronary Access After Redo-TAVR With BASILICA or Chimney Stenting in Degenerated Supra-Annular Self-Expanding Platforms.

TCT 745: Indications and 3-Year Outcomes of Redo-TAVR for Degenerated Transcatheter Aortic Valves: Experience from a Single High-Volume Center in Germany

TCT 676: Safety and Early Outcomes of the Navitor Transcatheter Heart Valve: A Multicenter 'Real World' Study in the United Kingdom

Comparison of Two Self-Expanding Transcatheter Heart Valves for Degenerated Surgical Bioprostheses: The AVENGER Multi-Center Registry

TCT 716: Impact of Different Lifetime Management Strategies on Coronary Access: Valve-in-Valve versus TAVR-in-TAVR

Pharmacotherapy to Slow AS Progression and Protect the Heart

TCT 574: Estimating risks to coronary obstruction and prosthesis-patients mismatch after redo-transcatheter aortic valve replacement using computed tomography-derived 2nd transcatheter aortic valve sizing

TCT 610: Predictors of Readmission and Resource Utilization in Transcatheter Aortic Valve Implantation with and without Mitral Stenosis - A National Readmission Database Study

Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content